Education and Training
- Resident, Internal Medicine, Barnes-Jewish Hospital, 1986 - 1989
- M.D., Washington University School of Medicine, 1986
Berg, C. L., M. M. Jonas, and B. R. Bacon. “Treatment of Hereditary Hemochromatosis, Wilson Disease, and Other Metabolic Disorders of the Liver,” December 1, 2006, 487–502. https://doi.org/10.1016/B978-1-4160-0317-5.50038-8.
Caldwell, Stephen H., Maureane Hoffman, Ton Lisman, B Gail Macik, Patrick G. Northup, K Rajender Reddy, Armando Tripodi, Arun J. Sanyal, and Arun J. Coagulation in Liver Disease Group. “Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management.” Hepatology 44, no. 4 (October 2006): 1039–46. https://doi.org/10.1002/hep.21303.
Northup, P. G., T. L. Pruett, G. J. Stukenborg, and C. L. Berg. “Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era.” Am J Transplant 6, no. 10 (October 2006): 2455–62. https://doi.org/10.1111/j.1600-6143.2006.01501.x.
Northup, Patrick G., Matthew M. McMahon, A Parker Ruhl, Scott E. Altschuler, Agata Volk-Bednarz, Stephen H. Caldwell, and Carl L. Berg. “Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.” Am J Gastroenterol 101, no. 7 (July 2006): 1524–28. https://doi.org/10.1111/j.1572-0241.2006.00588.x.
Berg, C., F. L. Goncales, D. E. Bernstein, H. Sette, J. Rasenack, M. Diago, D. M. Jensen, P. Graham, and G. Cooksley. “Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin.” J Viral Hepat 13, no. 7 (July 2006): 435–40. https://doi.org/10.1111/j.1365-2893.2006.00727.x.
Dickinson, D. M., T. H. Shearon, J. O’Keefe, H. -. H. Wong, C. L. Berg, J. D. Rosendale, F. L. Delmonico, R. L. Webb, and R. A. Wolfe. “SRTR center-specific reporting tools: Posttransplant outcomes.” Am J Transplant 6, no. 5 Pt 2 (2006): 1198–1211. https://doi.org/10.1111/j.1600-6143.2006.01275.x.
Northup, Patrick G., Ryan C. Wanamaker, Vanessa D. Lee, Reid B. Adams, and Carl L. Berg. “Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis.” Ann Surg 242, no. 2 (August 2005): 244–51. https://doi.org/10.1097/01.sla.0000171327.29262.e0.